Orellanine specifically targets renal clear cell carcinoma

Lisa Buvall(AstraZeneca (United Kingdom)), Jenny Nyström(University of Gothenburg), Jan Törnell, Sven Lundstam(Sahlgrenska University Hospital), Börje Haraldsson(University of Gothenburg), Anders Herrmann(National Food Administration), Carina Sihlbom(University of Gothenburg), Deman Najar(University of Gothenburg), Kerstin Ebefors(University of Gothenburg), Martin Johansson(Sahlgrenska University Hospital), Alina Khramova(University of Gothenburg), Ulf Nilsson(University of Gothenburg), Emelie Roos(University of Gothenburg), Lovisa Bergwall(University of Gothenburg), Heidi Hedman(University of Gothenburg), Hanna Wallentin(University of Gothenburg)
Oncotarget
July 25, 2017
Cited by 26


Related Papers